11/01/2024
4:15 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
4:00 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form ARS | |
10/11/2024
7:46 AM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form DEF 14A | |
09/27/2024
4:10 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
5:44 PM | ORBIMED ADVISORS LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
| Form SC 13D | |
09/23/2024
3:42 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
4:06 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/17/2024
4:11 PM | Greenwood Luba (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
4:12 PM | Greenwood Luba (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:02 AM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 424B3 | |
08/28/2024
11:15 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form EFFECT | |
08/23/2024
4:15 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
6:30 AM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
5:03 AM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form NT 10-Q | |
08/09/2024
5:00 AM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form DEF 14A | |
08/07/2024
2:46 PM | Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4/A | |
08/07/2024
2:47 PM | Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4/A | |
07/30/2024
2:14 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form PRER14A | |
07/19/2024
3:01 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
3:49 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/21/2024
4:21 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:20 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K/A | |
05/22/2024
4:25 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:27 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024
3:15 PM | Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/12/2024
3:11 PM | ORBIMED ADVISORS LLC (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3/A | |
04/11/2024
4:41 PM | TPAV, LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3/A | |
04/08/2024
8:37 PM | Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Viriom, Inc. (Filed by)
| Form SC 13D | |
04/03/2024
7:01 PM | Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:03 PM | CAUTREELS WERNER (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:04 PM | Pauza Charles David (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:07 PM | Redfield Robert (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:50 PM | Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:51 PM | TPAV, LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:53 PM | CAUTREELS WERNER (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:54 PM | Pauza Charles David (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:55 PM | Redfield Robert (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:56 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:57 PM | Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Viriom, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:59 PM | Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:47 PM | Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
03/15/2024
4:36 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:40 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:48 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Subject)
Traws Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
3:49 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics, Inc. (Subject)
Traws Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
4:36 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:38 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:09 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Subject)
Traws Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
